Transcardiac 5-hydroxytryptamine release and impaired coronary endothelial function in patients with vasospastic angina

Clinical and Experimental Pharmacology and Physiology

Volumn 25, Issue 12, 1998, Pages 999-1003

  Murakami, Yo ^a   Shimada, Toshio ^a   Ishinaga, Yuji ^a   Kinoshita, Yoshihisa ^a   Kin, Hakutetsu ^a   Kitamura, Jun ^a   Ishibashi, Yutaka ^a   Murakami, Rinji ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Coronary endothelium; Platelet; Vasospastic angina

Indexed keywords

GLYCERYL TRINITRATE; SEROTONIN;

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CORONARY SINUS; DEGRANULATION; DRUG EFFECT; FEMALE; HUMAN; MALE; SEROTONIN BLOOD LEVEL; SEROTONIN RELEASE; THROMBOCYTE; VASCULAR ENDOTHELIUM; VASOSPASM;

EID: 0032442204     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1998.tb02173.x     Document Type: Article

References (27)

1. Robertson RM, Robertson DR, Friesinger GC, Timmons S, Hawiger J. Platelet aggregates in peripheral and coronary-sinus blood in patients with spontaneous coronary-artery spasm. Lancet 1980; ii: 829-31.
2. 2 levels in patients with classic and variant angina pectoris. Circulation 1981; 6: 1107-15.
3. Report of a meeting of physicians and scientists. Platelet activation and arterial thrombosis. Lancet 1994; 344: 991-5.
4. Alevriadou BR, Moake JL, Turner NA et al. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Hematology 1993; 81: 1263-76.
5. Ashton JH, Benedict CR, Fitzgerald C et al. Serotonin is a mediator of cyclic flow variations in stenosed canine arteries. Circulation 1986; 73: 572-8.
6. Radomski MW, Vallance P, Whitley G, Foxwell N, Moncada S. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc. Res. 1993; 27: 1380-2.
7. Radomski MW, Palmer RMJ, Moncada S. The anti-aggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide. Br. J. Pharmacol. 1987; 92: 639-46.
8. Murakami Y, Ishinaga Y, Sano K et al. Increased serotonin release across the coronary bed during a nonischemic interval in patients with vasospastic angina. Clin. Cardiol. 1996; 19: 473-6.
9. Kugiyama K, Yasue H, Okumura K et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996; 94: 266-72.
10. Radomski MW, Moncada S. Regulation of vascular homeostasis by nitric oxide. Thromb. Haemost. 1993; 70: 36-41.
11. Yang Z, Arnet U, Bauer E et al. Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane-A2. Circulation 1994; 89: 2266-72.
12. Fitagerald DJ, Roy L, Catella F, Fitzgerald GA. Platelet activation in unstable coronary disease. N. Engl. J. Med. 1986; 315: 983-9.
13. Willerson JT, Campbell WB, Winniford MD et al. Conversion from chronic to acute coronary artery disease: Speculation regarding mechanisms. Am. J. Cardiol. 1984; 54: 1349-54.
14. Murakami Y, Ishinaga Y, Sano K et al. Circadian release of serotonin across the coronary bed in patients with endothelial dysfunction. Am. J. Cardiol. 1997; 80: 214-16.
15. Oshima S, Yasue H, Ogawa H, Okumura K, Matsuyama K. Fibrinopeptide A is released into the coronary circulation after coronary spasm. Circulation 1990; 82: 2222-5.
16. Golino P, Piscione F, Benedict C et al. Local effect of serotonin released during coronary angioplasty. N. Engl. J. Med. 1994; 330: 523-8.
17. van den Berg EK, Schmitz JM, Benedict CR, Malloy CR, Willerson JT, Dehmer GJ. Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. Circulation 1989; 79: 116-24.
18. Junod AF. Metabolism, production and release of hormones and mediators in the lung. Am. Rev. Respir. Dis. 1975; 112: 93-108.
19. Gillia CN, Oitt BR. The fate of circulating amines within the pulmonary circulation. Annu. Rev. Physiol. 1982; 44: 269-81.
20. Eynard N, Flachaire E, Lestra C et al. Platelet serotonin content and free and total plasma tryptophan in healthy volunteers during 24 hours. Clin. Chem. 1993; 39: 2337-40.
21. Ogawa H, Yasue H, Oshima S, Okumura K, Matsuyama K, Obata K. Circadian variation of plasma fibrinopeptide A levels in patients with variant angina. Circulation 1989; 80: 1617-26.
22. Pohl U, Busse R. EDRF increases cyclic GMP in platelets during passage thorugh the coronary vascular bed. Circ. Res. 1989; 65: 1798-803.
23. Watanabe H, Kakihata M, Ohtsuka S, Enomoto T, Yaui K, Sugishita Y. Platelet cyclic GMP. A potentially useful indicator to evaluate the effects of nitroglycerin and nitrate tolerance. Circulation 1993; 88: 29-36.
24. Toyo-oka T, Aizawa T, Suzuki N et al. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 1991; 83: 476-83.
25. Cosigny PM. Endothelin-1 increases arterial sensitivity to 5-hydroxytryptamine. Eur. J. Pharmacol. 1990; 186: 239-45.
26. McFadden EP, Clarke JG, Davies GJ, Kaski JC, Haider AW, Maseri A. Effect of intracoronary serontonin on coronary vessels in patients with stable angina and patients with variant angina. N. Engl. J. Med. 1991; 324: 648-54.
27. Tousoulis D, Davies G, McFadden E, Clarke J, Kaski JC, Maseri A. Coronary vasomotor effects of serotonin in patients with angina. Relation to coronary stenosis morphology. Circulation 1993; 88: 1518-26.